Cargando…
Recent advances in the understanding and management of primary hyperparathyroidism
Primary hyperparathyroidism is a hormonal disorder whose prevalence is approximately 1–2% in the United States of America. The disease has become more recognizable to clinicians in an earlier phase and, at present, patients can be diagnosed with “classic”, “normocalcemic”, “normohormonal”, or “mild,...
Autores principales: | Goldfarb, Melanie, Singer, Frederick R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043104/ https://www.ncbi.nlm.nih.gov/pubmed/32148764 http://dx.doi.org/10.12688/f1000research.21569.1 |
Ejemplares similares
-
Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020) -
Recent advances in the management and understanding of macular degeneration
por: Bahadorani, Sepehr, et al.
Publicado: (2017) -
Advances in the diagnosis and the management of primary hyperparathyroidism
por: Islam, Ana Kashfia
Publicado: (2021) -
Role of SPECT and SPECT/CT in the Surgical Treatment of Primary Hyperparathyroidism
por: Taubman, Michele L., et al.
Publicado: (2011) -
Medical management of primary hyperparathyroidism
por: Bandeira, Francisco, et al.
Publicado: (2022)